Patient Demographics and Response to JAK Inhibitor Therapy

Published: 17 February 2025| Version 1 | DOI: 10.17632/yp8v2z9kct.1
Contributor:
Aubrey Martin

Description

This table presents a summary of various studies investigating the use of Janus kinase (JAK) inhibitors in treating different forms of scarring alopecia.

Files

Institutions

  • Lahey Hospital and Medical Center Burlington

Categories

Dermatology, Alopecia

Licence